Login

Corteva Inc

Recommendation: Buy

Entry Date Symbol Recommendation Entry Price (USD) Target 1 (USD) Target 2 (USD) Holding Duration Position Status Return(%)*
9 Jan, 26 CTVA Buy USD 70.14 USD 73.5 USD 77.0 20 days Closed 4.79%

*Return(%) represent the percentage change between the entry price and exit price of the recommendation.

Fundamentals

  • Previous Close 77.37
  • Market Cap54037.30M
  • Volume13360340
  • P/E Ratio45.91
  • Dividend Yield0.88%
  • EBITDA3799.00M
  • Revenue TTM17401.00M
  • Revenue Per Share TTM25.59
  • Gross Profit TTM 8229.00M
  • Diluted EPS TTM1.75

Data Powered by EOD Historical Data (“EODHD”).

Company Overview

Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.

Key Positives

Acceleration in Net Sales Growth: In Q3 FY25, Corteva reported net sales of USD 2,618 million, representing a 13% year-on-year increase from USD 2,326 million in Q3 FY24

Sharp Improvement in Operating EBITDA: The company delivered a significant turnaround in operating profitability, with Operating EBITDA improving to USD 49 million in Q3 FY25 from an Operating EBITDA loss of USD 100 million in Q3 FY24

Key Negatives

Pricing Pressure in Crop Protection: The Crop Protection segment experienced ongoing competitive pricing dynamics in Q3 FY25, especially in Latin America, limiting price-led growth relative to Q3 FY24

Continued Net Loss Position: Despite the improvement in profitability metrics, Corteva remained loss-making at the net level, reporting GAAP EPS of (USD 0.46) in Q3 FY25, compared with (USD 0.76) in Q3 FY24

Key Investment Risks

Corteva’s investment profile remains exposed to risks from volatile agricultural markets, adverse weather conditions, currency fluctuations, competitive pricing pressures in Crop Protection, and execution risks associated with its planned business separation

Recommendation Summary

Technical Summary

Entry Price Support* Target 1** Target 2**
70.14 63.126 73.5 77.0

Data Source: REFINITIV, Analysis: StockNextt

*Support can be considered as an indicative stop-loss, and if prices move below that level on closing basis individuals may evaluate exiting the position depending on their risk appetite, previous holdings, and other factors considered. The support and resistance levels may need to be re-evaluated within 4-6 weeks’ time frame depending on the stock price movements from the date of recommendation on the stock.

**Target prices may vary by ±0.5% depending on market volatility.

Key Reasons for Buy

Revenue Growth and Top-Line Momentum: Corteva delivered a robust improvement in its top-line performance during Q3 FY25, with net sales increasing to USD 2,618 million compared to USD 2,326 million in Q3 FY24, reflecting a 13% year-on-year growth. This growth was primarily driven by strong volume expansion across both the Seed and Crop Protection segments, supported by early safrinha demand in Latin America and sustained farmer preference for premium technologies.

Operating Profitability and Margin Expansion: The company reported a marked turnaround in operating profitability, with Operating EBITDA improving to USD 49 million in Q3 FY25 from a loss of USD 100 million in Q3 FY24. Correspondingly, the Operating EBITDA margin expanded sharply from (4.3%) in Q3 FY24 to 1.9% in Q3 FY25, reflecting significant benefits from cost productivity initiatives, lower input costs, and improved price discipline, partially offset by currency headwinds.

Earnings Performance and Loss Reduction: Corteva continued to narrow its losses at the net earnings level. GAAP loss from continuing operations after tax reduced to USD 308 million in Q3 FY25, compared with USD 519 million in Q3 FY24, representing a 41% year-on-year improvement. Operating EPS also improved materially to (USD 0.23) in Q3 FY25 from (USD 0.49) in Q3 FY24, supported by higher operating income and improved cost control.

Seed Segment Operational Execution: The Seed business demonstrated strong operational momentum during the quarter, underpinned by significant price/mix gains and volume growth. Demand for advanced corn hybrids and improved out-licensing income supported margin recovery, while productivity benefits and lower commodity input costs helped offset higher R&D and compensation expenses. Early safrinha deliveries in Brazil further contributed to regional volume strength.

Crop Protection Segment Performance: The Crop Protection segment recorded steady growth, with net sales supported by double-digit volume growth in new products and biologicals. While competitive pricing pressures persisted in certain Latin American markets, productivity gains and lower raw material costs enabled margin expansion. The company’s focus on differentiated technologies and biologically derived solutions continued to strengthen its portfolio resilience.

Cash Flow, Capital Allocation, and Balance Sheet Strength: Corteva maintained strong financial discipline, achieving improved free cash flow generation driven by higher EBITDA and lower cash taxes. Management reaffirmed its commitment to shareholder returns, remaining on track to return approximately USD 1.5 billion to shareholders in FY25, including USD 1 billion in share repurchases, supported by a solid balance sheet and liquidity position.

Considering recent key business, financial updates, current trading levels, and key business risks, a ‘Buy’ recommendation has been given on Corteva, Inc. (NYSE: CTVA) at the closing market price of USD 70.14, as on Jan 08, 2026.

Key Financials in Pictures

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Data Powered by EOD Historical Data (“EODHD”).

Peer Comparison

Sector: Basic Materials Industry: Agricultural Inputs

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CTVA
Corteva Inc
1.22 1.58% 78.59 45.91 22.22 3.11 2.23 2.99 16.92
NTR
Nutrien Ltd
-1.42 2.21% 62.86 54.62 15.27 1.14 1.17 1.64 10.45
CF
CF Industries Holdings Inc
-2.92 2.76% 102.93 12.92 13.97 2.63 3.85 2.86 6.18
MOS
The Mosaic Company
0.39 1.73% 22.90 9.17 11.07 0.78 0.98 1.00 5.38
YARIY
Yara International ASA
- -% 22.77 16.03 10.56 0.52 1.25 0.71 5.89

Data Powered by EOD Historical Data (“EODHD”).

Disclosures:

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Related Risks: This report may be looked at from high-risk perspective and recommendations are provided are for a short duration. Recommendations provided in this report are solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels as on January 9, 2026. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned has been achieved and is subject to the factors discussed above.

Note 4: StockNextt reports are prepared based on the stock prices captured either from REFINITIV or Trading View. Typically, REFINITIV or Trading View may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.
Target: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Target 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Target 2 may act as the crucial resistance level for the stock.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.

Disclaimer :
This report has been issued by StockNextt which has an Ontario Business Identification Number 1000958347 and British Columbia registration Number FM1051529 is a trade name under Kalkine Canada Advisory Services Inc. having Business Number 761925130BC0001. Kalkine Canada Advisory Services Inc. and StockNextt are collectively referred to as “StockNextt”, “we”, “us”, and “our”. The website https://stocknextt.com and associated pages are published by StockNextt. The information in this report and on the StockNextt website has been prepared from a wide variety of sources, which StockNextt, to the best of its knowledge and belief, considers accurate. StcokNextt has made every effort to ensure the reliability of information contained in its reports, newsletters, and websites. All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain general recommendations for investing in securities and other financial products. StockNextt does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. StockNextt does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. StockNextt’s general advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested. Please also read our Terms and conditions for further information. Employees and/or associates of StockNextt and its related entities may hold an interest in the securities or other financial products covered in this report or on the StockNextt website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Copyright © 2026 Krish Capital Pty Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.